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Abstract
Background: Endothelial cells (ECs) are continuously exposed to hemodynamic forces imparted by blood flow. While it is
known that endothelial behavior can be influenced by cytokine activation or fluid shear, the combined effects of these two
independent agonists have yet to be fully elucidated.
Methodology: We investigated EC response to long-term inflammatory cues under physiologically relevant shear conditions
via E-selectin expression where monolayers of human umbilical vein ECs were simultaneously exposed to laminar fluid shear
and interleukin-1ß (shear-cytokine activation) in a parallel plate flow chamber.
Results and Conclusion: Naı ¨ve ECs exposed to shear-cytokine activation display significantly higher E-selectin expression
for up to 24 hr relative to ECs activated in static (static-cytokine). Peak E-selectin expression occurred after 8–12 hr of
continuous shear-cytokine activation contrary to the commonly observed 4–6 hr peak expression in ECs exposed to static-
cytokine activation. Cells with some history of high shear conditioning exhibited either high or muted E-selectin expression
depending on the durations of the shear pre-conditioning and the ensuing shear-cytokine activation. Overall, the presented
data suggest that a high laminar shear enhances acute EC response to interleukin-1ß in naı ¨ve or shear-conditioned ECs as
may be found in the pathological setting of ischemia/reperfusion injury while conferring rapid E-selectin downregulation to
protect against chronic inflammation.
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Introduction
Located at the interface between the vascular wall and the
bloodstream, the endothelium (a monolayer of endothelial cells)
plays a critical role in several physiological processes including
angiogenesis, thrombosis, regulation of blood pressure, and
inflammation. Endothelial cell (EC) response has also been
implicated in the pathogenesis and pathology of many human
diseases. In particular, the EC chronic inflammation response is
known to have a prominent role in cancer metastasis and
atherogenesis (development of plaque in arteries), a precursor to
coronary artery disease [1,2,3,4,5,6]. The differential response of
ECs to fluid shear stress and various chemical agonists such as
tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) results
in the differential surface expression of various leukocyte adhesion
molecules (LAMs) by the endothelium (e.g. selectins, ICAM-1 and
VCAM-1) and is critical to the balance between healthy and
pathogenic inflammation response [7,8,9,10]. The ability to
discriminate between healthy and diseased tissue through EC
adhesion molecule expression patterns will have profound
consequences for developing diagnostic tools and targeted
therapeutic for the treatment of several human diseases. Despite
this potential, endothelial behavior under chronic inflammation
has yet to be fully elucidated, even after decades of research. While
more complex in vitro assays to model EC inflammation response
have been developed, many of these fail to encompass the true
physiological conditions under which inflammation occurs.
To date, most published works on inflammation research have
focused on in vitro endothelial response to various inflammatory
agonist (e.g. TNF-a) and antagonist (e.g. statins) in static cultures
[11,12,13,14,15] or to mechanical stresses imparted by shear flow
of various type (steady or disturbed) and magnitude
[16,17,18,19,20]. Limited works have been done to understand
the combined effect of both chemical and mechanical stimuli – a
more appropriate representation of the in vivo occurrence of
inflammatory response. Works that have explored these models
have mostly done so in a less than physiological manner, e.g. ECs
are first exposed to fluid shear stress (i.e. pre-conditioned) and
then subjected to chemical stimuli under static conditions [21].
Additionally, simultaneous shear-cytokine induced EC response is
typically observed in limited time frames [22,23,24]. TNF-a has
also been the major focus of existing EC shear-cytokine activation
studies though other cytokines are known to be a key regulator
of inflammation response, e.g. IL-1b has been implicated in the
pathology of several human diseases, including chronic autoim-
mune diseases [25], Alzheimer’s disease [26], and metabolic
syndromes such as atherosclerosis, chronic heart failure, and
diabetes [27,28]. Finally, the majority of these studies have also
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than E-selectin perhaps due to previous reports of the latter’s
insensitivity to shear stress [22,29]. The interaction of EC surface-
expressed selectins (E and P-selectin) with their counter receptors
(sLe
X and PSGL-1, respectively) expressed on leukocyte surfaces,
however, is critical to the initiation of leukocyte margination – a
hallmark of inflammation response [30]. Moreover, E-selectin is
often associated with leukocyte recruitment and disease progres-
sion in many chronic inflammatory diseases, e.g. increased levels of
E-selectin and high leukocyte infiltration is found in rheumatoid
arthritis, chronic lung infections and several cardiovascular
diseases [31,32,33,34].
In general, understanding longer-term endothelial response to
inflammatory cues via surface expression of LAMs would provide
invaluable insight into its role in pathological conditions and offer
new opportunities for treatment. Thus, the present study aimed to
explore the temporal cell-surface expression of E-selectin by human
umbilical vein endothelial cells (HUVEC) in response to IL-1b
stimulation under laminar shear conditions. We specifically focused
on cell-surface (apical) E-selectin expression over time since this
directly translates to the temporal level of leukocyte margination
[35,36]. We found that E-selectin is expressed on HUVEC surface
in previously unreported patterns where the magnitude and pattern
of expression is simultaneously dependent on the magnitude of the
imposed fluid shear, the shear history of the ECs, and the length of
exposure to chemical stimuli.
Materials and Methods
Ethics Statement
All human protocols were approved by the University of
Michigan (UM) Internal Review Board (IRB protocol numbers
HUM00013973 and HUM00026898) and in line with the
standards set by the Helsinki Declaration. A written informed
consent approved by the UM IRB was obtained from all
participants involved in the study prior to blood collection. Data
collection and analyses were performed anonymously.
Cell Culture
All cell culture reagents were obtained from Invitrogen (Carlsbad,
CA) unless otherwise noted. HUVECs were isolated from fresh
umbilical cords following a modified Jaffe protocol [37,38]. Cords
were collected from Mott’s Children Hospital (Ann Arbor, MI)
following an Internal Review Board (IRB) exempt protocol, and
HUVECs used in all assays were pooled from at least 3 donors.
Isolated cells were collected and plated in 0.2% (w/v) gelatin (Sigma
Aldrich, St. Louis, MO) surface-treated tissue culture flasks and
cultured until confluent inHUVECmedia that consisted of Medium
199 supplemented with 10% (v/v) fetal bovine serum (HyClone,
Logan, Utah),10% (v/v) bovine calfserum (HyClone, Logan, Utah),
1% 250 mg/mL fungizone, 1% 5,000 U/mL penicillin/5,000 mg/
mL streptomycin, 1% 200-mM L-glutamine, 1% 10 mg/mL
heparin, 1% 1 M HEPES buffer and 50 mg/ml endothelial cell
growth supplement (BD Biosciences, Franklin Lakes, NJ).
For static and shear flow experiments, HUVECs were
trypsinized (0.25% trypsin-EDTA) and subcultured onto 30 mm
glass coverslips (Warner Instruments, Hamden, CT) coated with
1% w/v gelatin cross-linked with glutaraldehyde (Polysciences,
Warrington, PA) as previously described [39]. Coverslips were
incubated for at least 36 hr in a humidified, 5% CO2,3 7 uC
environment prior to use. HUVEC monolayers cultured as
described can maintain their integrity when exposed to laminar
flow of up to 20 dynes cm
22 [38]. HUVECs were not used in
experiments beyond passage 2.
Parallel Plate Flow Chamber Setup
A straight channel parallel plate flow chamber (PPFC)
(GlycoTech, Gaithersburg, MD) was used for all shear studies
[40]. Briefly, a silicon rubber gasket with a rectangular cutout was
attached to an acrylic flow chamber deck with inlet and outlet flow
ports. A glass coverslip with confluent HUVEC monolayer was
placed over the gasket and vacuum-sealed such that the coverslip
formed the bottom plate of the flow chamber. A rectangular
cutout in the gasket defined the flow channel with a height of
254 mm. The PPFC was connected via 1.8 mm inner diameter
Tygon tubing to inlet and outlet media reservoirs. A height
difference between reservoirs determined the flow rate through the
PPFC; a programmable peristaltic pump (Ismatec, Germany) was
used to recirculate media to the inlet reservoir. The entire
apparatus was maintained in a humidified 5% CO2,3 7 uC
chamber built around a Nikon TE 2000-S inverted microscope.
Activation of Endothelial Cells
For static conditions, HUVEC monolayers were exposed to a
single dose of 0.1 ng ml
21 of recombinant human interleukin-1ß
(IL-1ß – Fitzgerald Industries, Concord, MA) for the desired
period of time (up to 24 hr). Preliminary experiments showed
maximal E-selectin expression with an IL-1ß concentration of
0.01 ng ml
21 at the 4 hr activation mark under static conditions.
For shear conditions, HUVEC monolayers were exposed to a
fixed wall shear (in the range of 1–20 dyn cm
22) via flow of cell
culture media in either the absence or presence of IL-1ß for a
given period of time up to 24 hr. The wall shear stress (dyn cm
22)
in the flow chamber was computed as previously described [38].
Quantification of HUVEC E-selectin Surface Expression
Coverslips with HUVEC monolayers from static and flow assays
were washed with DPBS
++ and fixed via exposure to 4% w/v
paraformaldehyde for 10 min at 4uC. Cells were washed twice
with DPBS
++ and incubated with 0.2 mg ml
21 fluorescein-
conjugated monoclonal anti-human E-selectin antibody (BBIG-
E5 clone, R&D Systems, Minneapolis, MN) at 4uC for at least 1 hr
to label surface-expressed protein only – no cell permeabilizing
agent was used. After labeling, monolayers were affixed to flow
chambers in their original orientation in order to maintain a
consistent imaging depth; chambers were flushed with DPBS
++ to
clear cell surface debris and unbound antibodies. Monolayer
surface E-selectin expression was imaged on a fluorescent
microscope (Nikon ET 2000 S) at 485/527 nm (ex/em) and
2000 ms exposure using a Photometrics CoolSNAP EZ (Photo-
metrics, Tucson, AZ) mounted on a Sony CCD sensor digital
camera; images were captured using MetaMorph software
(Downingtown, PA). A representative fluorescent image of EC
E-selectin expression is shown in Figure S1. Relative fluorescent
intensities (RFI) were collected for five images per monolayer near
the PPFC flow centerline at least 1 cm from the flow inlet. To
convert RFI values to antibody concentration, average fluorescent
intensities for 0.2, 0.1, 0.05, and 0.00 mgm l
21 solutions of the
anti-human E-selectin antibody were measured on a calibration
monolayer for a linear regression fit. Measured RFI values for
each monolayer were then converted to E-selectin sites per mm
2
(assuming 1:1 binding ratio of antibody to receptor).
Neutrophil Binding Assays
Human blood was collected from donors via venipuncture into
a syringe containing citrate anticoagulant (acetate-citrate-dex-
trose). Red blood cells (RBCs) were separated from whole blood by
sedimentation using a 6% (w/v) dextran solution. Neutrophils
Shear-Cytokine Activated E-Selectin Expression
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described [39]. Isolated neutrophils were washed with DPBS
2 at
room temperature and used within 2 hr of isolation. Neutrophil
adhesion to IL-1ß treated (up to 24 hr) HUVEC monolayers
under static- or shear-cytokine conditions were assessed in the
PPFC described above. An activated monolayer was loaded onto
the flow deck, and freshly isolated human neutrophils in DPBS
++
with 1% (w/v) human serum albumin (1610
6 cells ml
21) were
perfused over the monolayer at 2 dyn cm
22. Binding density was
calculated as the number of adherent or rolling neutrophils per
mm
2 after 2 minutes of shear.
Statistical Methods
All experiments were performed in at least triplicate; averages
were calculated and standard errors are shown on data figures
unless otherwise noted. Significance was determined using
student’s t-test for one-on-one comparisons and one-way ANOVA
with a 95% confidence interval and Bonferroni post-test using
GraphPad Prism Software (San Diego, CA) for comparison
between groups.
Results
HUVEC Response to Simultaneous Exposure to IL-1ß and
Laminar Shear
Figure 1 shows the E-selectin surface expression density for
HUVEC monolayers activated with shear alone (10 dyn cm
22),
IL-1ß in static (static-cytokine hereafter), or IL-1ß in shear flow
(shear-cytokine; 10 dyn cm
22). Naı ¨ve monolayers exposed to a
single dose of static-cytokine activation exhibited increased E-
selectin expression from basal expression (untreated cells; ,9.0
sites mm
22) to levels as high as 111 sites mm
22 at 4 hr (peak
expression). E-selectin expression subsequently decreased to values
only slightly significant from baseline by 16 hr (p=0.030; unpaired
t-test). At 24 hr of static-cytokine activation, expression slightly
rebounded to a level 3.4 times higher than baseline expression
(p=0.0057; unpaired t-test). When IL-1ß activation was done in
the simultaneous presence of laminar shear at 10 dyn cm
22 (shear-
cytokine), HUVEC monolayers expressed significantly higher
levels of E-selectin than that observed for static-cytokine activation
at all time points from 8 to 24 hr. The same level of expression was
recorded at 4 hr for both shear-cytokine and static-cytokine
treated monolayers. E-selectin density on shear-cytokine activated
cells was also not significantly different at 4 and 24 hr of activation
time whereas the 24 hr level for static-cytokine activated cells was
3.5 fold lower than their corresponding 4 hr expression. As shown
in Figure 1, monolayers exposed to laminar shear alone displayed
minimal E-selectin expression not significant from the basal
expression for up to 24 hr.
An extension of the fluid shear stress studied to 5 and 20 dyn
cm
22 showed that the peak E-selectin expression for all shear-
cytokine activation shifted to the 8 to 12 hr range with the same
magnitude of expression over static-cytokine activation as shown
in Figure 2A. Surprisingly, even at the low shear magnitude of 1
dyn cm
22, peak expression also shifted to 8–12 hr with levels
comparable to that observed at 10 dyn cm
22. Specifically, the E-
selectin expression by monolayer exposed to 1 dyn cm
22 of shear-
cytokine activation was not significant at the 8 hr mark from
values measured for monolayers exposed to 5 and 10 dyn cm
22 at
the same time point (one-way Anova). Expression levels also
remained elevated relative to static-cytokine for most activation
times greater than 4 hr at this low shear-cytokine activation.
Overall, the 24 hr expression in shear-cytokine activated mono-
layers exposed to at least 5 dyn cm
22 of shear remained 2–3 folds
higher than the 24 hr expression measured for static-cytokine
treated ECs and were comparable to the expression level at 4 hr of
static-cytokine activation. The E-selectin density at 24 hr for 1 dyn
cm
22 of shear-cytokine activation was not significant from
the expression at 24 hr for static-cytokine. Thus, we examined
additional shear stress magnitudes between 1 and 5 dyn cm
22 for
the 24 hr activation time point. As shown in Figure 2B, a linear
correlation between E-selectin density and shear magnitude was
observed from static-cytokine activation up to 2 dyn cm
22 of
shear-cytokine activation. The selectin densities measured for
shear magnitudes from 2 to 20 dyn cm
22 shear-cytokine activation
were not significant from each other. Overall, endothelial
monolayer integrity was maintained for up to 24 hr in the range
of laminar shear stresses studied here (see Figure S2), and all
monolayer exposed to shear (alone or with cytokine) were found to
elongate in the direction of flow as previously reported in the
literature [41,42].
To determine whether upregulation (surface expression) of new
E-selectin molecules rather than altered downregulation of
previously expressed molecules contributed to the higher density
observed with shear-cytokine activation at the 8–12 hr mark
relative to static-cytokine, experiments were conducted with a non-
lethal concentration of cycloheximide (CHX) (see Figure S3), an
inhibitor of protein synthesis in eukaryotes, added to the shear-
activation media at the 4 hr activation time point. Specifically,
CHX was added to the media (at 1.0 mgm L
21) over EC
monolayers that had been activating for 4 hr in static or shear
conditions (thus CHX only affected protein expression beyond
4 hr). Monolayers treated with CHX remained under static- or
shear-cytokine activation for an additional 8 hr period. E-selectin
levels were quantified at the 12 hr activation mark. As shown in
Figure 3A, the 12 hr E-selectin expression for monolayers exposed
to shear-cytokine activation in the presence of CHX was
significantly lower than values measured for monolayers exposed
to shear-cytokine activation alone but was not significant from
values measured for static-cytokine activation in the presence or
Figure 1. E-selectin expression (sites mm
22) in static-cytokine,
shear-cytokine and shear only activated monolayers. HUVEC
monolayers were exposed to laminar shear alone at 10 dyn cm
22 (gray)
or activated with 0.1 ng ml
21 IL-1ß either under static culture (solid) or
simultaneously exposed to fluid shear stress (clear) at 10 dyn cm
22.
‘‘NS’’ indicates no significance, ‘‘**’’ p,0.01, and ‘‘***’’ p,0.001.
doi:10.1371/journal.pone.0031874.g001
Shear-Cytokine Activated E-Selectin Expression
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measured for EC exposed to shear-cytokine activation is due to
additional (new) E-selectin being expressed on the apical surface
and not delayed/altered downregulation.
The functionality of shear-cytokine-induced E-selectin mole-
cules was evaluated relative to static-cytokine via neutrophil flow
adhesion assays since E-selectin expression level on endothelial
cells is known to correlate with the level of leukocyte adhesion
during inflammation response [35,36]. As shown in Figure 3B,
HUVEC monolayers subjected to shear-cytokine activation at 10
dyn cm
22 supported significantly higher levels of neutrophil
adhesion at the 8–24 hr activation time points when compared
with monolayers activated under static conditions (1.6–2.4 folds
higher). Monolayers exposed to static-cytokine activation showed
Figure 2. E-selectin expression (sites mm
22) on 0–20 dyn cm
22 shear-cytokine activated monolayers. (A) Contour plot of E-selectin
expression by HUVEC monolayers activated with 0.1 ng ml
21 IL-1ß either under static conditions (no fluid shear) or simultaneously exposed to 1, 5,
10 or 20 dyn cm
22 of laminar fluid shear at activation periods ranging from 0 to 24 hr. Note: This is a plot of data collected at discrete time points and
shear levels as indicated on the x and y axes, respectively. (B) Expression at 24 hr only. ‘‘NS’’ indicates no significance, ‘‘*’’ p,0.05, ‘‘**’’ p,0.01, and
‘‘***’’ p,0.001 when compared to static-cytokine activation at the same time point.
doi:10.1371/journal.pone.0031874.g002
Figure 3. Cycloheximide (CHX) inhibition of E-selectin synthesis and neutrophil binding assays for static- and shear-cytokine
activated monolayers. (A) E-selectin expression on cycloheximide-treated monolayers. CHX at a non-lethal concentration of 1 mgm L
21 was added
to HUVEC monolayers at 4 hr activation time in both static (‘‘SA-CHX,’’ diagonal stripes) and shear-cytokine (10 dyn cm
22, ‘‘FA-CHX,’’ horizontal
stripes) conditions. Static (‘‘SA,’’ solid) and shear-cytokine (‘‘FA,’’ white) controls were not treated with CHX. (B) Neutrophil binding density over
HUVEC monolayers activated with 0.1 ng ml
21 IL-1ß under static culture or 10 dyn cm
22 shear for 4, 8, 12, and 24 hr periods. ‘‘NS’’ indicates no
significance, ‘‘***,’’ p,0.001, and ‘‘**,’’ p,0.05.
doi:10.1371/journal.pone.0031874.g003
Shear-Cytokine Activated E-Selectin Expression
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that value for the 24 hr activation. Neutrophil binding densities
were similar between static- and shear-cytokine activation at the
4 hr time point in agreement with protein expression data.
Effect of Shear Preconditioning on Shear-Cytokine
Activation
To more accurately represent physiological conditions, mono-
layers were preconditioned with low (1 dyn cm
22) or high laminar
fluid shear (10 dyn cm
22) for up to 20 hr prior to shear-cytokine
activation (at same shear magnitude). As shown in Figure 4A, ECs
preconditioned for 4 hr with high shear prior to shear-cytokine
activation displayed E-selectin expression levels comparable to
naı ¨ve shear-cytokine activated monolayers (‘‘0 PS’’) with maxi-
mum expression occurring at 8–12 hr post activation. However,
monolayers exposed to high shear preconditioning for 8, 12, and
16 hr prior to a 4 hr of shear-cytokine activation expressed E-
selectin at levels 1.3–1.5 folds higher than naı ¨ve monolayers
activated in static or shear-cytokine (controls) conditions for 4 hr.
A further increase in preconditioning time to 20 hr, however,
resulted in a significant drop in E-selectin expression in response to
4 hr of shear-cytokine activation relative to shear cytokine (naı ¨ve
and preconditioned) and static activated monolayers at this shear-
cytokine activation time point. Beyond the 4 hr shear-cytokine
activation time point, all preconditioned monolayers exhibited E-
selectin at levels lower than their corresponding shear-cytokine
control. Monolayers subjected to 8 hr preconditioning, however,
expressed higher levels of protein (2–2.6 folds higher) relative to
static-cytokine control at all shear-cytokine activation times greater
than 4 hr. E-selectin levels on monolayers preconditioned for
12 hr remained elevated against static-cytokine activation (1.4 fold
higher) at 8 hr shear-cytokine activation whereas the level on
16 hr preconditioned monolayers did not. E-selectin expression on
both 12 and 16 hr preconditioned monolayers dropped to levels
not significant from the static-cytokine control at the 12 hr shear-
cytokine activation mark, but both remained significantly different
from static at the 16 hr activation mark.
Contrary to observations for high shear preconditioning,
monolayers preconditioned for 8 or 12 hr with 1 dyn cm
22 of
laminar shear (Figure 4B) showed a muted response to shear-
cytokine activation at the same magnitude of shear, displaying
significantly lower E-selectin expression when compared to the
corresponding shear-cytokine activated controls at all activation
times.
Effect of Cytokine Redosing
In order to simulate chronic inflammation (maintained exposure
to a constant IL-1ß concentration), monolayers were subjected to
multiple doses (redosing hereafter) of IL-1ß over time. Specifically,
HUVEC monolayers were activated with an initial 0.1 ng ml
21
IL-1ß dose under static or fluid shear (10 dyn cm
22) conditions.
Every four hours, spent culture media was removed from cells and
replaced with fresh media containing the initial dose of IL-1ß.
Monolayers redosed in static- or shear-cytokine activation
conditions expressed similar E-selectin densities when compared
to non-redosed controls at the 4 and 8 hr activation times as
shown in Figure 5. Static-cytokine treated monolayers show a
significant response to redosing at the 12 and 24 hr marks with
higher E-selectin expression than non-redosed samples (1.8 and
5.2 fold higher, p,0.01) whereas shear-cytokine treated cells only
showed a significant difference between redosed and control
samples (1.7 fold higher, p,0.01) at the 24 hr mark. The effect of
redosing on shear preconditioned ECs was also studied. For
monolayers exposed to 8 hr shear preconditioning at 10 dyn cm
22
followed by shear-cytokine activation for up to 16 hr, E-selectin
expression was not significantly different between monolayers
redosed with IL-1ß every 4 hr and ones subjected to only an initial
dose of IL-1ß at 0 hr as shown in Figure 6.
Discussion
The endothelium plays critical roles in the regulation of natural
processes as well as pathological events such as chronic
inflammation and cancer metastasis. Thus, understanding the
Figure 4. E-selectin expression (sites mm
22) on shear preconditioned monolayers. Site density on HUVECs preconditioned with (A) 10 dyn
cm
22 or (B) 1 dyn cm
22 of laminar shear for 4, 8, 12, 16 or 20 hr (‘‘4PS,’’ ‘‘8PS,’’ ‘‘12PS,’’ ‘‘16PS,’’ and ‘‘20PS,’’ respectively) prior to activation with
0.1 ng ml
21 IL-1ß under similar magnitude of shear. Filled bar=static activation controls and clear bar=‘‘0 PS’’ or monolayers were not
preconditioned. ‘‘NS’’ indicates no significance, ‘‘***,’’ p,0.001, and ‘‘**,’’ p,0.05.
doi:10.1371/journal.pone.0031874.g004
Shear-Cytokine Activated E-Selectin Expression
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including cytokines and mechanical forces imparted by blood flow,
has long been a focus of biomedical research. In inflammation
response, the endothelium modulates the margination of blood
leukocytes via differential expression of leukocyte adhesion
molecules with the selectins (E and P) being important for their
initial adhesive interactions. The ability to identify and quantify
the expression patterns for these markers is invaluable for the
design of sophisticated vascular-targeted diagnostics or therapeutic
systems useful in the many diseases that chronic inflammation is
known to have a role. In vitro assays with human ECs are critical to
the aforementioned prospect since tools that allow for the imaging
of protein expression in vivo are currently lacking. One major
drawback of previously described in vitro models, especially in
attempting to represent a system as dynamic as the vascular tissue,
is in not adequately simulating the physiological conditions under
which inflammation occurs. Specifically, only a few works in the
literature have explored any cytokine activation of cultured ECs in
the presence of physiologically relevant shear and even fewer
with IL-1ß and shear. However, it is well-known that ECs are
highly responsive to mechanical forces by way of morphological
alignment (e.g. transitioning from cobblestone to elongated shapes
after a period of laminar shear [43,44,45]) and surface expression
of some leukocyte adhesion proteins [46]. In the current study, we
investigated EC response to long-term inflammatory cues under
physiologically relevant shear conditions where monolayers of
human umbilical vein endothelial cells (HUVECs) were exposed to
simultaneous stimulation of laminar fluid shear and IL-1ß.
We show for the first time that the co-stimulation of naı ¨ve ECs
(not previously exposed to shear in vitro) with flow-induced shear
and IL-1b induces the expression of significantly higher levels of
functional E-selectin molecules up to 24 hr when compared with
monolayers stimulated under static condition only (Figure 1). This
is interesting since E-selectin expression by ECs is typically not
inducible by laminar shear alone [35,47,48] as was shown in
Figure 1 though one report showed a 4 fold increase in E-selectin
mRNA in human aortic ECs in response to 4.5 dyn cm
22 (but not
at .10 dyn cm
22) of laminar shear [49]. Similarly, peak E-selectin
expression is well-documented to occur between 4–6 hr in static-
cytokine stimulated cells compared to the 8–12 hr peak observed
with naı ¨ve cells under shear-cytokine activation (Figure 2A). As
shown in Figure 5B, maximal E-selectin expression was extended
Figure 5. E-selectin expression (sites mm
22) on IL-1ß redosed monolayers. Redosing HUVEC monolayers in (A) static-cytokine or (B) shear-
cytokine activation conditions. Control groups (filled and clear) were given only a single initial IL-1ß dose at the start of experiment. Redosed samples
(upward and downward diagonals) were given repeated doses of IL-1ß every 4 hr until immunofluorescence assay at 8, 12, or 24 hr total activation
time. Indicated significance values are comparing redosing and control data at the same timepoint. ‘‘NS’’ indicates no significance and ‘‘***,’’ p,0.001.
doi:10.1371/journal.pone.0031874.g005
Figure 6. E-selectin expression (sites mm
22) on preconditioned
and IL-1ß redosed monolayers. Site density of pre-conditioned
HUVECs subjected to 4 hr intervals of IL-1ß redosing. ‘‘Static-Cytokine’’
(filled) monolayers were activated with initial IL-1ß dose at 0 hrs under
static conditions; ‘‘PS-SD’’ (clear) monolayers were preconditioned
under 10 dyn cm
22 of shear alone for 8 hrs prior to a single IL-1ß dose
(under continued shear exposure); ‘‘PS-RD’’ (diagonal stripes) monolay-
ers were preconditioned for 8 hrs with shear alone and then given
repeated doses of IL-1ß (under continued shear exposure) every 4 hrs
for up to 16 hrs total activation time. ‘‘NS’’ indicates no significance.
doi:10.1371/journal.pone.0031874.g006
Shear-Cytokine Activated E-Selectin Expression
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lack of EC response to IL-1b redosing at earlier time points (4 and
8 hrs for static and up to 12 hr for shear-cytokine) is in line with
previous report by Pober et al. [15] where EC monolayers in static
were shown to express E-selectin levels at 30 hr that were
comparable to the 4 hr peak expression for a single dose only if the
redosing occurred at 24 hr for monolayers initially dosed for six
hours and rested (removal of cytokine) for eighteen hours. The
authors showed that redosing at the 24 hr mark of ECs that had
been under continuous presence of an initial IL-1b dose yielded no
response at the 30 hr mark. Thus, it is possible that the multiple
4 hr-interval redosing as presented in this work conditioned ECs
to better respond with higher E-selectin expression at the 12 and
24 hr mark for static- and shear-cytokine activation, respectively.
From the protein translation inhibition data presented in
Figure 3A, we conclude that the higher density of E-selectin on
shear-cytokine activated naı ¨ve ECs is likely associated with
increased surface expression of E-selectin rather than due to a
decrease in the E-selectin internalization rate. A previous report by
Kluger et al. that found E-selectin internalization rate on HUVEC
to be constant regardless of expression level further supports
this conclusion [50], and Kraiss et al. showed that shear stress
modulates TNF-a-induced expression of E-selectin at the protein
translation level [51]. The shear-cytokine newly-induced E-selectin
were found to be functional for leukocyte recruitment since
neutrophil adhesion density on shear-cytokine activated monolay-
ers relative to static-cytokine activated monolayers was found to
directly correlate to protein expression patterns as shown in
Figure 3B [36]. Interestingly, E-selectin expression under shear-
cytokine conditions appears to be insensitive to the magnitude of
shear imposed during shear-cytokine activation at most of the time
points studied (Figure 2). A shear threshold of 2 dyn cm
22 was
required at the 24 hr activation time to induce the same 3 folds
increase in E-selectin expression by naı ¨ve ECs at intermediate
activation times for shear-cytokine activation relative to static-
cytokine activation.
While at first glance, the E-selectin expression profile that
emerged for monolayers preconditioned at a high laminar shear
prior to shear-cytokine activation (Figure 4A) appears contradic-
tory to the profile observed for naı ¨ve cells in shear-cytokine
activation, a closer look suggests one similarity between the two.
Specifically, in both naı ¨ve and shear-conditioned ECs, the
optimum protein expression in response to shear-cytokine
activation occurs after cells had been exposed to at least eight
hours of flow-induced shear. This time frame coincides with that
for which naı ¨ve EC monolayers were previously observed to
realign and elongate in the direction of flow in response to shear
(see Figure S2) [52,53]. This observation further highlights the
active role that cell cytoskeleton may have in regulating E-selectin
protein expression as previously suggested by others [54,55].
Consistent with previous literature, the presented data shows
that laminar shear stress is protective against chronic inflammation
(.24 hr) in ECs that have been subjected to a prolonged period of
high shear prior to cytokine stimulation as would exist in
physiological occurrences of normal inflammation response
[56,57]. Most interesting, however, is the observation in
Figure 4A that naı ¨ve cells exposed to high shear prior to cytokine
exposure under shear conditions exhibited markedly higher E-
selectin expression in the first four hours of shear-cytokine
activation relative to naı ¨ve cells activated under static- or shear-
cytokine conditions. This phenomenon is not simply attributed to
cumulative shear exposure time as, for example, monolayers
preconditioned for 12 hr followed by 4 hr of shear-cytokine
activation exhibited ,2.5 fold higher E-selectin expression
compared to naı ¨ve cells exposed to 16 hr of shear-cytokine
stimulation. A minimum shear-preconditioning magnitude and
time threshold seems to be a requisite for this observation: higher
E-selectin expression relative to the 4 hr static-cytokine activation
was absent in monolayers preconditioned with low laminar shear
(1 dyn cm
22; Figure 4B) or for monolayers preconditioned for
times outside the 8–16 hr range. It is also interesting to note that
redosing of preconditioned ECs with fresh IL-1b during shear-
cytokine activation did not induce higher E-selectin expression
even at prolonged shear-cytokine activation times (Figure 6)
whereas a positive effect was observed in redosing of naı ¨ve cells
(Figure 5) particularly at the 24 hr mark. This highlights the robust
protection against chronic inflammation conferred by prior
exposure to high laminar shear, i.e. the individual sustained
synthesis or continual presence of an elevated concentration of
cytokine alone is not enough to induce chronic expression of E-
selectin in vivo in healthy vessels with high laminar shear. One
focus of our future work would be to explore any potential synergy
between multiple cytokines (e.g. IL-1b and TNF-a) and flow-
induced shear in the temporal EC expression of E-selectin and
other leukocyte adhesion molecules.
It is worth noting, however, that the observed shear-regulated
differential E-selectin expression may be cytokine-specific since a
previous report of TNF-a activation of shear preconditioned ECs
resulted in an expression level that was not significantly different
from that observed in unactivated naı ¨ve ECs in static, contrary to
the data reported here [24]. The same authors later showed
minimal neutrophil adhesion on HUVEC preconditioned with
high shear for 24 hr followed by a 3 hr TNF-a activation [21].
This discrepancy between EC response to IL-1b and TNF-a
activation in shear may be due to their distinct cell surface
receptors that effect slightly different EC signaling pathways [15].
However, Cicha et al. and Chiu et al. each independently showed
that HUVECs subjected to 18 and 24 hr of high shear
preconditioning followed by 2 and 4 hr of shear-cytokine (TNF-
a) activation, respectively, expressed E-selectin at levels signifi-
cantly higher than the unactivated controls with the latter study
showing a 4 fold lower E-selectin expression relative to static-
cytokine activated naı ¨ve ECs [22,23]. The conflicting reports on
the effect of shear preconditioning on EC response to TNF-a
stimulation is likely only resolved via a similar comprehensive
analysis of EC response to the combined shear-TNF-a stimulation
as is presented here for shear-IL-1b. Our future work will address
this.
In summary, we report for the first time that human EC
expression of E-selectin in response to IL-1b stimulation is
dependent on the shear history of these cells. Naı ¨ve cells
simultaneously exposed to IL-1b and high laminar shear display
strong pro-inflammatory phenotypes for an extended period
whereas cells first preconditioned with laminar shear exhibit
either elevated or muted inflammatory response dependent on the
time frame of the following shear-cytokine stimulation. While the
shear-cytokine stimulation of naı ¨ve or short-term preconditioned
cells (,24 hr) and their ensuing E-selectin expression pattern may
not be relevant in normal inflammation response, the presented
data likely provides insight into the pathological inflammatory
response in ischemia since IL-1b is known to be strongly involved
in the pathogenesis of ischemic brain damage and other acute and
chronic neurodegenerative disorders[58,59]. For example, the
elongated endothelial morphology conferred by flow is known to
be reversible upon cessation of flow [41,42]; thus the endothelium
downstream of a blood vessel obstruction or constriction (as seen
in atherosclerosis or thromboembolism) may acquire a naı ¨ve-like
phenotype dependent on the extent of ischemia. These ECs may
Shear-Cytokine Activated E-Selectin Expression
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E-selectin expression pattern (Figure 1) upon reperfusion wherein
cytokine present at the obstruction is delivered simultaneously with
flow induced-shear to downstream endothelial cells. Thus, it is
possible that an enhanced inflammatory EC phenotype (and
hence, elevated E-selectin expression) during flow reperfusion in
the presence of IL-1b in part contributes to the high level of
leukocyte recruitment that has been suggested as a cause of the
phenomenon of reperfusion injury [60,61]. This hypothesis may
be further substantiated by evidence of increased E-selectin
expression in microvessels in ischemic lesions after 4–24 hr of
reperfusion [62,63]. In one study, peak E-selectin expression was
measured after 10 hr of reperfusion consistent with the time frame
of the highest E-selectin expression by naı ¨ve and preconditioned
ECs as reported here (Figures 2 and 4) [63]. Evidence also exists
that the endothelial dysfunction associated in the reperfusion
phase is decoupled from any injury associated with the preceding
ischemia [64,65]. However, the use of HUVECs in this study may
limit the direct correlation of E-selectin expression to clinically
relevant ischemia/reperfusion injury. Our future work will explore
protein expression patterns in human ECs from other vascular
beds more prone to developing pathologies in response to various
combinations of steady and disturbed flow patterns and cytokine
stimulation.
Supporting Information
Figure S1 E-selectin expression on endothelial mono-
layer at 4 hrs static activation. HUVECs were exposed to
0.1 ng ml
21 IL-1ß under static conditions for 4 hrs. A fluorescent
(A) and brightfield (B) image of E-selectin labeled with FITC-
conjugated anti-human E-selectin antibody was captured at 106
magnification and overlaid to create a composite image (C).
(TIFF)
Figure S2 Images of endothelial morphology over long-
term shear-cytokine activation. Brightfield images at 206
magnification of HUVECs exposed to 0.1 ng ml
21 IL-1ß under
10 dyn cm
22 shear for (A) 0 hr, (B) 4 hr, (C) 8 hr, and (D) 24 hr.
(TIFF)
Figure S3 Endothelial monolayer integrity after treat-
ment with cylcoheximide and IL-1b. Monolayers were
simultaneously treated with 1.0 mgm l
21 of cycloheximide and
0.1 ng ml
21 IL-1ß in growth media. Brightfield images (206) were
captured at (A) 4 hrs and (B) 8 hrs.
(TIFF)
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